ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Single-Cell Transcriptomics Reveals FLS2-Dependent Hypoxia Signaling and ERF13-Mediated Transcription During flg22-Triggered Immunity.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Plant Phosphatidylinositol Signalling Network in Cotton Resistance to Verticillium Wilt.Plant, cell & environment · 2026Review
- Endophyte Bacillus sp. RE35 Enhances Cd Trap in Rice Roots Via Root Cell Wall Remodelling During Colonisation.Plant, cell & environment · 2026Article
- Functional Characterization ofPlants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
The flagellin peptide flg22 activates FLAGELLIN-SENSING 2 (FLS2)-mediated immunity in Arabidopsis, leading to growth inhibition and oxidative burst. While these responses are well-studied, their cell-type-specific regulation remains poorly understood. Using single-cell RNA sequencing, genetics, and phenotyping, we systematically mapped flg22-induced responses. flg22 suppressed growth and elevated reactive oxygen species (ROS) in wild-type, but not in fls2 mutants. Epidermal (EP_3) and mesophyll (MPC_2) cells showed FLS2-dependent transcriptional reprogramming. Pseudotime analysis revealed developmental trajectories toward immune-activated states. flg22 also induced a hypoxia-like response; hypoxic signaling mutants (ate1, prt6, zpr2) showed reduced flg22 sensitivity, indicating crosstalk between immune and hypoxia pathways. ERF13 was identified as a central regulator: erf13 mutants impaired flg22-triggered ROS and growth inhibition but enhanced effector-triggered immunity (ETI), while overexpressors showed stronger pattern-triggered immunity (PTI). flg22 altered ploidy and cell-cycle gene expression in WT, which was stabilized in ate1 and erf13 mutants. Cell-cycle mutants sim smr and e2fabc enhanced flg22 responses, whereas cpr5 was less sensitive. Thus, immune, hypoxia, and ROS signals converge via ERF13 to balance immunity and growth, providing a single-cell view of spatial immune organization and stress adaptation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.